GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Z

ZhuZhou QianJin Pharmaceutical Co 600479.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

10.60

-0.56%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About ZhuZhou QianJin Pharmaceutical Co

Its shares trade on Shanghai under the ticker 600479.SS. It has been listed since 12 March 2004. In the fiscal year to 31 December 2025, it reported revenue of CN¥3.63bn and net income of CN¥287.8m. At that date it held total assets of CN¥4.96bn and shareholders' equity of CN¥3.03bn.

Zhuzhou Qianjin Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Zhuzhou, Hunan. The company went IPO on 2004-03-12. The firm's main products include tablets, granules, pills, hard capsules, syrups, herbs, vinum and gels, among others. The firm is also involved in the businesses of cultural entertainment, logistics and distribution, as well as the provision of hygienic products.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
12 Mar 2004
Employees
5,133
Website
qjyy.com ↗

Leadership

Pay as last reported

  • Mr. Shun JianChairman of the Board, since 2015CN¥1.3m
  • Mr. Daozhong CaoVice Chairman of the Board, since 2023
  • Ms. Yihua PengFinance Director, Deputy General Manager
  • Mr. Zhiyong ChenGeneral ManagerCN¥939,100
  • Mr. Aiwei XieDeputy General Manager, Director, since 2004CN¥940,800
  • Mr. Yun GongDeputy General Manager
  • Ms. Yunjiao OuyangDeputy General Manager
  • Ms. Li ZhuSecretary of the BoardCN¥612,500
  • Mr. Jun ChenDirector
  • Ms. Yan ZengDirector
  • Mr. Shuyong ZhouDirector
  • Mr. Wen DiIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • The company employs 5133 full-time staff members in Zhuzhou.
  • Main products include tablets, granules, pills, and hard capsules.
  • The firm provides hygienic products alongside pharmaceutical manufacturing.

Weaknesses

  • The company operates in the Health Care sector in China.
  • Listed on the market since 12 March 2004.
  • Headquarters are located in the city of Zhuzhou.

Opportunities

  • The firm is involved in cultural entertainment business segments.
  • Logistics and distribution activities offer additional revenue streams.
  • Herbs and vinum products diversify the current portfolio.

Threats

  • Syrops and gels face competition in the market.
  • Pharmaceutical manufacturing requires strict regulatory compliance standards.
  • China's economic environment impacts local business operations.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.